Research Articles
Tag-Teaming Cancer: A New One-Two Punch for a Resistant Blood Cancer
Exploring a clinical trial combining panobinostat and carfilzomib for treating relapsed multiple myeloma with promising results.
Breaking Cancer's Code: How the Experimental Drug Brontictuzumab Targets the Notch Signaling Pathway
Explore how Brontictuzumab targets the Notch signaling pathway in cancer treatment through a groundbreaking Phase I clinical trial.
A Smarter Strike Against Blood Cancer: New Combo Therapy Shows Lasting Promise
New research shows Polatuzumab Vedotin combined with R-CHP offers promising results for Diffuse Large B-Cell Lymphoma patients with durable benefits.
More is Better? The Science Behind Four-Drug Combinations for Multiple Myeloma Treatment
A comprehensive analysis of four-drug versus three-drug regimens for newly diagnosed multiple myeloma, examining safety, efficacy, and clinical evidence.
Decoding Cancer's Blueprint: The 2011 Revolution in Personalized Medicine
Explore the groundbreaking 2011 Fritz Bender Symposium that transformed cancer treatment through personalized medicine approaches.